Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature

Fluorouracil plus oxaliplatin (L-OHP) (FOLFOX) plus bevacizumab (BV) therapy is commonly administered to patients with metastatic colorectal cancer. However, few reports have described L-OHP therapy in hemodialysis patients, and the efficacy and safety remain uncertain in this population. Here, we r...

Descripción completa

Detalles Bibliográficos
Autores principales: Funasaka, Chikako, Kanemasa, Yusuke, Shimoyama, Tatsu, Ohta, Akihito, Omuro, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751430/
https://www.ncbi.nlm.nih.gov/pubmed/31572155
http://dx.doi.org/10.1159/000502512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751430/
https://www.ncbi.nlm.nih.gov/pubmed/31572155
http://dx.doi.org/10.1159/000502512

Ejemplares similares